All Stories

  1. Cercarial Dermatitis (aka ‘Swimmers’ or ‘Duck Itch’) in New Zealand Lakes
  2. Narrative review and bibliometric analysis on infodemics and health misinformation: A trending global issue
  3. Consensus on the Use of JAKinibs for Atopic Dermatitis in Australia and New Zealand. An eDelphi by the Australasian Medical Dermatology Group
  4. An Overview of the Skin Microbiome, the Potential for Pathogen Shift, and Dysbiosis in Common Skin Pathologies
  5. Combining treat‐to‐target principles and shared decision‐making: International expert consensus‐based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis
  6. Trends in publication and collaboration of health-themed systematic reviews before and during the COVID-19 pandemic: A bibliometric study
  7. Cross‐sectional burden‐of‐illness study in atopic dermatitis (MEASURE‐AD) in Australia and New Zealand reveals impacts on well‐being
  8. Exploring the association between isotretinoin and sexual dysfunction: a comprehensive scoping review
  9. Pharmaceutical Management of Rosacea—An Australian/New Zealand Medical Dermatology Consensus Narrative
  10. Bridging AI development with clinical relevance—A scoping review of skin cancer models since CLEAR Derm. Where to next?
  11. Burden of proof—Critical flaws in the recommendations from the commission on human medicines Isotretinoin expert working group
  12. When science and evidence is not enough: challenging the recommendations from the Commission on Human Medicines Isotretinoin Expert Working Group
  13. Global research profile on monkeypox-related literature (1962–2022): A bibliometric analysis
  14. Discoid (nummular) eczema in the paediatric setting – An Australian/New Zealand narrative
  15. The epidemiology and treatment outcomes of pemphigus in Auckland, New Zealand
  16. Acute Severe Hepatitis of Unknown Etiology in Children: A Mini-Review
  17. Mamaku (New Zealand black tree fern) extract as a potential treatment for atopic dermatitis
  18. Bullous pemphigoid: Its incidence, mortality and clinical outcome in New Zealand
  19. Virtual lesion clinic – Evaluation of a teledermatology triage system for referrals for suspected melanoma
  20. A baseline patch test series for New Zealand
  21. SARS‐CoV‐2 (COVID‐19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology Group
  22. Isotretinoin in the management of acne vulgaris: practical prescribing
  23. Guidance on infection control and plume management with Laser and Energy‐Based Devices taking into consideration COVID‐19
  24. Management of chronic hand and foot eczema. An Australia/New Zealand Clinical narrative
  25. COVID‐19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement
  26. Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases
  27. E‐referrals and teledermatoscopy grading for melanoma: a successful model of care
  28. Retinoids in Rosacea
  29. Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrative
  30. Tribute to Reviewers
  31. Psoriasis and infection. A clinical practice narrative
  32. In situ and invasive melanoma in a high-risk, New Zealand, population: A population-based study
  33. Psoriasis and cancer. An Australian/New Zealand narrative
  34. Immediate irritant dermatitis from the passionvine hopper (Scolypopa australis)
  35. Monitoring methotrexate-induced liver fibrosis in patients with psoriasis: utility of transient elastography
  36. Dermoscopic ‘Chaos and Clues’ in the diagnosis of melanoma in situ
  37. Tribute to Reviewers
  38. Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration
  39. Consensus statement for the treatment of infantile haemangiomas with propranolol
  40. Tribute to Reviewers
  41. Low-Dose Isotretinoin for Seborrhoeic Dermatitis
  42. Very low‐dose isotretinoin in mild to moderate papulopustular rosacea; a retrospective review of 52 patients
  43. Phytophotodermatitis caused by Ficus pumila
  44. Better, sooner, more convenient: A successful teledermoscopy service
  45. On isotretinoin dosing, adverse effects, and efficacy: response.
  46. Narrowband UVB phototherapy in children: A New Zealand experience
  47. A pink papule
  48. Asymptomatic Papules Over the Proximal Nail Fold in a Child—Quiz Case
  49. Textbook of Pediatric Dermatology, 2nd edition
  50. Occupational contact dermatitis to hydrangea
  51. Do Women Have More Adverse Drug Reactions?
  52. Lichens
  53. Toxicodendron of the Southern Pacific
  54. Tazarotene
  55. Allergic contact dermatitis from lichen acids
  56. Allergic contact dermatitis from lavender fragrance in Difflam® gel